The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2009
Filed:
Apr. 18, 2007
James C Sutton, Pleasanton, CA (US);
Marion Wiesmann, Brisbane, CA (US);
Weibo Wang, Moraga, CA (US);
Mika Lindvall, Oakland, CA (US);
Jiong Lan, Moraga, CA (US);
Savithri Ramurthy, Walnut Creek, CA (US);
Anu Sharma, El Cerrito, CA (US);
Elizabeth J. Mieuli, Stanford, CA (US);
Liana M. Klivansky, Oakland, CA (US);
William Lenahan, San Leandro, CA (US);
Susan Kaufman, Lafayette, CA (US);
Hong Yang, Foster City, CA (US);
Simon C. NG, Walnut Creek, CA (US);
Keith Pfister, San Ramon, CA (US);
Allan S. Wagman, Belmont, CA (US);
Victoria Sung, San Francisco, CA (US);
Martin Sendzik, San Mateo, CA (US);
James C Sutton, Pleasanton, CA (US);
Marion Wiesmann, Brisbane, CA (US);
Weibo Wang, Moraga, CA (US);
Mika Lindvall, Oakland, CA (US);
Jiong Lan, Moraga, CA (US);
Savithri Ramurthy, Walnut Creek, CA (US);
Anu Sharma, El Cerrito, CA (US);
Elizabeth J. Mieuli, Stanford, CA (US);
Liana M. Klivansky, Oakland, CA (US);
William Lenahan, San Leandro, CA (US);
Susan Kaufman, Lafayette, CA (US);
Hong Yang, Foster City, CA (US);
Simon C. Ng, Walnut Creek, CA (US);
Keith Pfister, San Ramon, CA (US);
Allan S. Wagman, Belmont, CA (US);
Victoria Sung, San Francisco, CA (US);
Martin Sendzik, San Mateo, CA (US);
Novartis Vaccines and Diagnostics, Inc., Emeryville, CA (US);
Abstract
Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.